Navigation Links
Encision Announces Death of Chief Executive Officer Fred F. Perner
Date:9/3/2013

BOULDER, Colo., Sept. 3, 2013 /PRNewswire/ -- Encision Inc. (ECIA:PK) announced today that Fred F. Perner, 59, its Chief Executive Officer died unexpectedly on August 31 from an apparent heart attack.

Mr. Perner joined Encision in September 2011 as its Chief Executive Officer. He had over 30 years of experience in healthcare, including many years of experience in electrosurgery and endoscopy technologies. He held B.S. and M.B.A. degrees from Indiana University and a law degree from the University of Denver.

To maintain continuity in the oversight of the Chief Executive Officer's functions, the Board of Directors voted, effective today, to appoint Pat Pace, M.D. the company's Chairman, as Executive Chairman of the Board of Directors. Dr. Pace is an Advisor to EDG Partners, a healthcare focused private equity firm. Dr. Pace's background includes over 10 years of financial experience in the healthcare sector. From 2009 to 2011, he was a Managing Director at Citadel Securities, where he was part of the inaugural team that helped launch the firm's investment banking and credit sales and trading efforts. In this capacity, he provided credit analysis for the healthcare sector. From 2006 to 2009, he was a Vice President at AIG Investments, where he focused on healthcare investments in the high yield bond market. From 2001 to 2006, Dr. Pace held various positions at UBS, including serving as Senior Analyst in equity research covering the medical device sector from 2003 to 2006. Dr. Pace also serves as Chairman of the board of directors for Nanospectra Biosciences, Inc., a privately held medical device company. Dr. Pace holds an M.D. from the University of Texas Medical School – Houston and a B.A. (Honors in Psychology) from Vanderbilt University.

"Fred's leadership, energy, and vision that he dedicated to helping save patients' liv
'/>"/>

SOURCE Encision Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. From Encision Inc.: New Medicare Penalties to Include Laparoscopic Complications
2. Encision Names Patrick Pace, M.D. Chairman of the Board
3. Encision Reports First Quarter Fiscal Year 2014 Results
4. Encision to Release First Quarter 2013 Results on July 31, 2013
5. Encision Reports Fourth Quarter and Fiscal Year 2013 Results
6. Encision Inc. and Virtual Ports Ltd. Announce Exclusive Distribution Agreement for Laparoscopic Surgery Devices
7. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
8. Encision Reports Second Quarter of Fiscal Year 2013 Results
9. Encision Reports First Quarter of Fiscal Year 2013 Results
10. Sanomedics Announces Completion of Prime Time Medical Acquisition
11. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Neuraltus Pharmaceuticals, Inc. announced ... 2 clinical program of NP001 for the treatment of ... disease) are being highlighted today in an oral presentation ... Group , being held in Bloomington, Minnesota ... hoc  analysis, administration of a high dose of NP001 ...
(Date:9/17/2014)... 17 2014 IBM (NYSE: IBM ) ... IBM technical computing and storage technology to accelerate ... These services deliver critically important information to help ... unique cancer, which could lead to better health ... in general. Today, optimal cancer care ...
(Date:9/17/2014)... , September 17, 2014 ... to congratulate Biocartis commitment in shipping its first ... long-time investor in Biocartis as part of Debiopharm ... fully automated, real-time PCR based molecular diagnostics system, ... access to clinical molecular diagnostic information, anywhere and ...
Breaking Medicine Technology:Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2
... - NanoViricides,Inc. (Pink Sheets: NNVC) discussed today the ... presented along with the,successful BSL3 in vitro studies ... Annual Symposium of the Pan American Society for ... (Pan American Society,for Clinical Virology (PASCV): Clinical Virology ...
... and Symptom Severity; New,Resources for Patients, Parents, WASHINGTON, ... today by the National Consumers League shows that ... days. Four in,ten asthma sufferers understand asthma medication ... recent the diagnosis, the less,knowledgeable adult patients tend ...
Cached Medicine Technology:Global Rabies Treatment May be Possible with NanoViricides Drugs 2New Survey Finds Troubling Data on American Asthma Sufferers 2New Survey Finds Troubling Data on American Asthma Sufferers 3New Survey Finds Troubling Data on American Asthma Sufferers 4New Survey Finds Troubling Data on American Asthma Sufferers 5New Survey Finds Troubling Data on American Asthma Sufferers 6
(Date:9/17/2014)... York (PRWEB) September 17, 2014 The ... increase in worth due to the key driving factors ... advancements. An expected CAGR of 8.2 % puts the ... $730.2 million in 2018, as stated in a Transparency ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2012 ...
(Date:9/17/2014)... news release is available in Spanish . ... affect more than half of the population in our ... one of which affects liver function. Fat accumulates in ... causes inflammation, fibrosis and finally, cirrhosis. To date, the ... hepatic biopsy. Imaging techniques such as abdominal ecography detect ...
(Date:9/17/2014)... of America (GSA) invites all journalists to attend ... country,s largest interdisciplinary conference in the field of aging ... Media representatives may register free of charge. , An ... gathering at the Walter E. Washington Convention Center and ... "Making Connections: From Cells to Societies" and the program ...
(Date:9/17/2014)... Representatives with Capitol Pain Institute announced ... League Event at the Four Seasons in Austin, Texas. , ... honor to be a sponsor for this great event,” said ... went on to explain that the event, the Torch of ... members at the Four Seasons to honor Torch of Liberty ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Neon Sport ... part in the fitness industry’s most anticipated event, Joe ... NV. Two fans will each take home a Neon ... Neon Sport supplements and gear. Fitmark will hold entries ... Olympia Expo, September 19-20th. , “There’s nothing more ...
Breaking Medicine News(10 mins):Health News:Metrology Services Market to Hit USD 720.3 Million by 2018: Transparency Market Research 2Health News:Metrology Services Market to Hit USD 720.3 Million by 2018: Transparency Market Research 3Health News:Magnetic resonance helps to detect and quantify fat in liver 2Health News:Join GSA in Washington, DC, for the Nation's Premier Aging Conference 2Health News:Capitol Pain Institute Sponsoring an Anti-Defamation League Event & Awards Dinner 2Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2
... ... Pricing Discount! , ... UK (PRWEB) May 12, 2010 -- Citywide Cleaning Services - a division of Citywide Ventures ... 10% pricing discount on any new cleaning contracts. Also, the Company announced that it will ...
... pattern that predicts the likelihood of relapse in patients ... leukemia has been discovered. Researchers publishing in the open ... consistent pattern in five genes that has the potential ... from more aggressive treatment when first diagnosed with T-cell ...
... ... features allow even more companies to save money through better contract management by reduciing ... ... -- Network Contract Solutions has released new features allowing holding companies to take advantage ...
... allergy even exist, researchers find , TUESDAY, May ... information about the prevalence, diagnosis and treatment of food ... studies. , The articles looked at allergies to cow,s ... which account for more than 50 percent of all ...
... Center announced today that it has received a US$100,000 ... Gates Foundation. The grant will support an innovative ... assistant professor in the Department of Microbiology and Immunology, ... Immune Intervention." Joshi,s project is one of 78 ...
... goal of a secure nationwide health information network (NHIN), a ... evaluating the costs, effort and value of what is sometimes ... which appears in the May/June 2010 issue of Journal ... the initial assessment of that framework by health information exchange ...
Cached Medicine News:Health News:Cleaning Service Pricing Discount 2Health News:Genetic pattern that predicts leukemia relapse discovered 2Health News:Network Contract Solutions Adds Holding Company Features to Extend Market Reach and Client Base 2Health News:Few High-Quality Studies on Food Allergies, Say Reviewers 2Health News:OUHSC receives $100,000 Grand Challenges Explorations grant for innovative global health research 2Health News:Measuring success: Regenstrief helps assess value of investment in health info tech 2
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: